USP Drug Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Adrenal)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
   Angioedema Agents
   Immunosuppressants
   Immunostimulants
   Immunoglobulins
   Immunological Agents, Other
     B lymphocyte Stimulator-specific Inhibitor
     Complement Inhibitor
     Interleukin Blockers
       Anakinra
       Brodalumab
       Canakinumab
       Dupilumab
       Guselkumab
       Ixekizumab
       Rilonacept
       Risankizumab
       Sarilumab
       Secukinumab
       Siltuximab
       Tildrakizumab
       Tocilizumab
         D02596  Tocilizumab (USAN/INN)
       Ustekinumab
     JAK Inhibitor
     Selective Adhesion-Molecule Inhibitor
     Selective T-cell costimulation modulators
     Miscellaneous
     Allergen-specific immunotherapy
   Vaccines
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 3, 2020
According to the USP Drug Classification 2020

» Japanese version